Benign neoplasm of brain
MONDO:0021451A benign neoplasm that involves the brain.
Also known as: benign brain neoplasm, benign brain tumor, benign brain tumour, benign neoplasm of the brain, benign tumor of brain, benign tumor of the brain, benign tumour of brain, benign tumour of the brain
1526 clinical trials for this condition and its sub-types, 16 tagged with Benign neoplasm of brain itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Benign neoplasm of brain
-
Benign choroid plexus neoplasm 0 trials · 2 incl. sub-types
1 sub-type
- Choroid plexus papilloma 2 trials
-
Benign neoplasm of cerebrum 0 trials · 2 incl. sub-types
2 sub-types
- Cerebral hemangioma 0 trials · 2 incl. sub-types Sub-types →
- Cerebral hemisphere lipoma 0 trials Sub-types →
-
Intracranial hemangioma 0 trials · 2 incl. sub-types
4 sub-types
- Brain hemangioma 0 trials · 2 incl. sub-types Sub-types →
- Brain stem hemangioblastoma 0 trials
- Cerebellar hemangioblastoma 0 trials
- Intracranial cavernous angioma 0 trials
-
Pineocytoma 1 trial
-
Benign neoplasm of brain stem 0 trials
1 sub-type
- Brain stem hemangioblastoma 0 trials
-
Benign neoplasm of cerebellum 0 trials
2 sub-types
- Cerebellar hemangioblastoma 0 trials
- Cerebellar pilocytic astrocytoma 0 trials
-
Benign neoplasm of pituitary gland 0 trials
Most studied deeper sub-types
-
Proton beam therapy shows promise in tumor control trial
Disease control CompletedThis study tested the Varian ProBeam proton therapy system in 47 people with solid tumors. The goal was to see if the device safely controls tumors and meets performance standards. Patients received proton radiation and were followed for up to 5 years after treatment.
Sponsor: Varian, a Siemens Healthineers Company • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New proton beam machine shows promise in tumor control trial
Disease control CompletedThis study tested a new proton therapy device, the Varian ProBeam360°, in 47 people with solid tumors. The goal was to see if it could control tumor growth with few severe side effects. Participants received radiation for 1 to 8 weeks and were followed for up to 5 years. The main…
Sponsor: Varian, a Siemens Healthineers Company • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New Gadolinium-Free MRI dye shows promise for brain scans
Diagnosis CompletedThis study tested a new MRI contrast agent called RVP-001, made with manganese instead of gadolinium, in 18 adults with known brain lesions (like tumors or multiple sclerosis). The goal was to see if it is safe and can detect lesions as well as current gadolinium-based dyes. Each…
Phase 2 • Sponsor: Reveal Pharmaceuticals Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 08:06 UTC
-
A brainstem dose limit might spare brain tumor patients from radiation nausea
Knowledge-focused CompletedThis study looks at whether the amount of radiation reaching a small brainstem region, the dorsal vagal complex, is linked to nausea in people receiving radiation for benign brain tumors. Researchers will track nausea scores and radiation doses in 100 adults. The goal is to find …
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC